Page last updated: 2024-08-21

alpha-aminopyridine and Hematologic Malignancies

alpha-aminopyridine has been researched along with Hematologic Malignancies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Deng, M; Gao, Y; Gong, Y; Jia, Y; Ling, Y; Liu, X; Yang, C; Yang, Y; Zhou, Y1
Cao, HY; Dai, HP; Li, L; Xue, SL1
Abdel-Wahab, O; Abramson, D; Arcila, ME; Berger, MF; Ceyhan-Birsoy, O; De Munck, S; Decaux, O; Diamond, EL; Drilon, A; Dunkel, IJ; Durham, BH; Emile, JF; Erickson, C; Geissmann, F; Haroche, J; Hyman, DM; Ki, M; Lacouture, ME; Ladanyi, M; Lopez Rodrigo, E; Lu, SX; Mandelker, D; Mora, J; Pannecoucke, E; Pastore, A; Petrova-Drus, K; Picarsic, J; Rotemberg, V; Saganty, R; Santa-María López, V; Savvides, SN; Solit, DB; Ulaner, GA; Walsh, M; Yabe, M; Yoshimi, A1
Albert, DH; Ansell, P; Arellano, M; Garcia-Manero, G; Kadia, T; Kantarjian, H; Khoury, HJ; Knight, EA; McKee, MD; Munasinghe, W; Oliver, B; Qin, Q; Ricker, JL; Roberts-Rapp, L; Tibes, R; Xiong, H1

Reviews

1 review(s) available for alpha-aminopyridine and Hematologic Malignancies

ArticleYear
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.
    Hematological oncology, 2023, Volume: 41, Issue:3

    Topics: Aminopyridines; Apoptosis; Benzamides; Cell Line, Tumor; Epigenesis, Genetic; Hematologic Neoplasms; Histone Deacetylases; Humans

2023

Trials

1 trial(s) available for alpha-aminopyridine and Hematologic Malignancies

ArticleYear
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.
    Investigational new drugs, 2015, Volume: 33, Issue:4

    Topics: Aged; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Azacitidine; Female; Hematologic Neoplasms; Humans; Male; Maximum Tolerated Dose; Phenylurea Compounds; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor

2015

Other Studies

2 other study(ies) available for alpha-aminopyridine and Hematologic Malignancies

ArticleYear
Design, synthesis and in vitro biological evaluation of 2-aminopyridine derivatives as novel PI3Kδ inhibitors for hematological cancer.
    Bioorganic & medicinal chemistry letters, 2023, 02-15, Volume: 82

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Hematologic Neoplasms; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors

2023
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
    Nature medicine, 2019, Volume: 25, Issue:12

    Topics: Adolescent; Adult; Aminopyridines; Anaplastic Lymphoma Kinase; Benzothiazoles; Child; Child, Preschool; Exome Sequencing; Female; Genome, Human; Hematologic Neoplasms; Histiocytosis; Humans; Infant; Male; Mutation; Picolinic Acids; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Pyrazoles; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Twins, Monozygotic; Young Adult

2019